COVID-19: US FDA Weighing UK Anaphylactic Reaction Reports For Pfizer Vaccine Labeling

 
• By Sue Sutter
Reports of severe allergic reactions with Pfizer's vaccine in the UK may influence US labeling. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers